세계의 당뇨병성 족부궤양 치료 시장 보고서(2025년)
Diabetic Foot Ulcer Treatment Global Market Report 2025
상품코드 : 1821627
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,469,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,350,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,232,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

당뇨병성 족부궤양 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.5%로 110억 달러로 성장할 것입니다. 예측 기간의 성장은 당뇨병 인식 개선 캠페인의 증가, 맞춤형 의료 접근법, 환자 중심 치료 모델, 가치 기반 건강 관리 이니셔티브, 지속적인 의료 교육에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 상처 관리 제품의 기술 발전, 다학제 진료팀, 오프로딩 기술의 중요성, 생물학적 활성 드레싱 재료의 통합, 비용 효율적인 외래 치료 옵션, 고압 산소 요법의 사용 증가 등을 들 수 있습니다.

향후 5년간 8.5%의 성장률 예측은 이 시장에 대한 이전 예측에서 0.3%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 독일과 아일랜드에서 조달하는 고급 상처 드레싱 재료와 대체 피부의 비용을 상승시키고, 치유 시간을 지연시키거나 족부과 지출을 증가시킴으로써 미국의 발목을 잡을 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

당뇨병성 족부궤양 치료 시장은 당뇨병 환자 증가로 인해 성장이 예상됩니다. 당뇨병은 장기적인 영향을 미치는 대사성 질환으로 혈당 상승에 크게 기여하고 다양한 신체 기능에 실질적인 해를 끼치는 질환입니다. 당뇨병은 족부궤양의 주요 원인이며, 이에 따라 효과적인 당뇨병성 족부궤양 치료에 대한 수요가 증가하고 있습니다. 미국 질병통제예방센터(Centers for Disease Control and Prevention)는 2022년 당뇨병 환자 수가 약 3,730만 명으로 전체 인구의 11.3%를 차지할 것으로 예상하고 있습니다. 국제당뇨병연맹은 전 세계적으로 약 5억 3,700만 명의 성인이 당뇨병을 앓고 있으며, 선진국과 개발도상국 모두에 큰 영향을 미치고 있다고 강조하고 있습니다. 당뇨병 유병률의 증가는 당뇨병성 족부궤양 치료 시장의 성장을 촉진하는 중요한 요인입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

A diabetic foot ulcer is a skin sore with full-thickness skin loss on the foot, resulting from neuropathic and vascular complications in individuals with diabetes mellitus. These ulcers impede the healing process and increase susceptibility to infections, potentially leading to serious complications, including the need for amputation if not properly addressed. Diabetic foot ulcer treatment aims to prevent, treat, and manage these ulcers in diabetic patients.

The primary types of diabetic foot ulcer treatment include wound care dressings, biologics, therapy devices, antibiotic medications, and other interventions. Wound care dressings are sterile pads used to cover wounds, promoting healing and protecting against further damage. Various types of ulcers are classified as neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers, categorized by grades 1 through 5 based on severity. Diabetic foot ulcer treatments are utilized by hospitals, ambulatory surgery centers, and other end-users in the healthcare sector.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The diabetic foot ulcer treatment market research report is one of a series of new reports from The Business Research Company that provides diabetic foot ulcer treatment market statistics, including diabetic foot ulcer treatment industry global market size, regional shares, competitors with a diabetic foot ulcer treatment market share, detailed diabetic foot ulcer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic foot ulcer treatment industry. This diabetic foot ulcer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diabetic foot ulcer treatment market size has grown strongly in recent years. It will grow from $7.43 billion in 2024 to $7.94 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising diabetes prevalence, increased awareness and early detection, improved patient education, government initiatives and healthcare policies, multidisciplinary approach to care, wound care guidelines and protocols.

The diabetic foot ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $11 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing diabetes awareness campaigns, personalized medicine approaches, patient-centric care models, value-based healthcare initiatives, continuous medical education. Major trends in the forecast period include technological advances in wound care products, multidisciplinary care teams, emphasis on offloading techniques, integration of bioactive dressings, cost-effective and outpatient treatment options, increased use of hyperbaric oxygen therapy.

The forecast of 8.5% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S.by increasing the cost of advanced wound dressings and skin substitutes sourced from Germany and Ireland, thereby delaying healing times and elevating podiatry department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The diabetic foot ulcer treatment market is poised for growth due to the rising number of diabetes patients. Diabetes, a metabolic illness with long-term effects, significantly contributes to elevated blood glucose levels, leading to substantial harm to various bodily functions. Diabetes is a major cause of foot ulcers, resulting in a heightened demand for effective diabetic foot ulcer treatment. Notably, in 2022, the Centers for Disease Control and Prevention reported around 37.3 million people in the United States suffering from diabetes, comprising 11.3% of the population. Globally, the International Diabetes Federation highlighted approximately 537 million adults with diabetes, emphasizing the considerable impact on both developed and developing countries. The increased prevalence of diabetes is a key factor propelling the growth of the diabetic foot ulcer treatment market.

The diabetic foot ulcer treatment market is set for growth driven by the increasing geriatric population. As individuals aged 65 or older are more susceptible to chronic diseases, including diabetes, cardiovascular issues, and cancer, specialized medical care becomes essential. Elderly individuals, despite comorbidities and dependencies, have a probability of healing from diabetes-related foot ulcers. The World Health Organization predicts a significant rise in the global geriatric population, reaching 1.4 billion individuals aged 60 or older by 2030, doubling to 2.1 billion by 2050. This demographic trend contributes to the growth of the diabetic foot ulcer treatment market as a result of age-related health challenges.

Technological advancement is a significant trend in the diabetic foot ulcer treatment market. Major players in the market are concentrating on innovative technologies, including cloud-based AI technology for the detection of diabetic foot ulcers. For example, in August 2024, Ipca Laboratories, an Indian multinational pharmaceutical company, launched the first-of-its-kind topical gel, Diulcus, specifically for diabetic foot ulcers (DFU) in India. Ipca has priced the Diulcus 15 mg gel at Rs 1365 per pack and will soon distribute it through its extensive network of 4,000 distributors across India.

Major companies in the diabetic foot ulcer treatment market are concentrating on introducing innovative solutions, such as ON101, to gain a competitive advantage. Innovative solutions for diabetic foot ulcer treatment encompass new and advanced methods for managing and healing foot ulcers in individuals with diabetes. For instance, in October 2023, Oneness Biotech Co., a Taiwan-based pharmaceutical firm, launched ON101, a novel cream (brand name Fespixon) designed for the topical treatment of diabetic foot ulcers (DFUs). The ON101 cream is an effective solution for chronic, non-healing DFUs that have not responded to conventional therapies. Clinical trial results show that the wound-healing cream is beneficial for diabetic foot ulcers, with participants reporting a 60% complete healing rate over 16 weeks, surpassing the 35% healing rate observed with absorbent wound dressings.

In August 2023, Coloplast, a Denmark-based company that creates products and services for individuals with medical conditions, acquired Kerecis for an undisclosed amount. Following the acquisition, both companies are collaborating to enhance and broaden the availability of innovative solutions for patients suffering from diabetic foot ulcers. Their combined product offerings present various wound care approaches, providing healthcare professionals with a wider range of options to address the specific needs of their patients. Kerecis is an Iceland-based company that specializes in treating diabetic foot ulcers using fish skin grafts.

Major companies operating in the diabetic foot ulcer treatment market are Coloplast A/S, Medtronic PLC, Molnlycke Health Care AB, B. Braun Melsungen AG, Medline Industries Inc., ConvaTec Inc., Acelity L.P. Inc., 3M Healthcare, Smith & Nephew PLC, Organogenesis Inc., BSN Medical GMBH, Integra LifeSciences Corporation, Derma Sciences Inc., Advancis Medical, Tissue Regenix Group PLC, MiMedx Group Inc., Kerecis, Human Regenerative Technologies LLC, AOTI Inc., Lohmann & Rauscher International GmbH & Co. KG, Urgo Medical, L&R USA Inc., Misonix Inc., Bioventus, Cellumed Co. Ltd.

North America was the largest region in the diabetic foot ulcer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic foot ulcer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diabetic foot ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetic foot ulcer treatment market includes revenues earned by entities by ultrasound therapy, negative pressure wound therapy, and active therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetic Foot Ulcer Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetic foot ulcer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for diabetic foot ulcer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetic foot ulcer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Diabetic Foot Ulcer Treatment Market Characteristics

3. Diabetic Foot Ulcer Treatment Market Trends And Strategies

4. Diabetic Foot Ulcer Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Diabetic Foot Ulcer Treatment Growth Analysis And Strategic Analysis Framework

6. Diabetic Foot Ulcer Treatment Market Segmentation

7. Diabetic Foot Ulcer Treatment Market Regional And Country Analysis

8. Asia-Pacific Diabetic Foot Ulcer Treatment Market

9. China Diabetic Foot Ulcer Treatment Market

10. India Diabetic Foot Ulcer Treatment Market

11. Japan Diabetic Foot Ulcer Treatment Market

12. Australia Diabetic Foot Ulcer Treatment Market

13. Indonesia Diabetic Foot Ulcer Treatment Market

14. South Korea Diabetic Foot Ulcer Treatment Market

15. Western Europe Diabetic Foot Ulcer Treatment Market

16. UK Diabetic Foot Ulcer Treatment Market

17. Germany Diabetic Foot Ulcer Treatment Market

18. France Diabetic Foot Ulcer Treatment Market

19. Italy Diabetic Foot Ulcer Treatment Market

20. Spain Diabetic Foot Ulcer Treatment Market

21. Eastern Europe Diabetic Foot Ulcer Treatment Market

22. Russia Diabetic Foot Ulcer Treatment Market

23. North America Diabetic Foot Ulcer Treatment Market

24. USA Diabetic Foot Ulcer Treatment Market

25. Canada Diabetic Foot Ulcer Treatment Market

26. South America Diabetic Foot Ulcer Treatment Market

27. Brazil Diabetic Foot Ulcer Treatment Market

28. Middle East Diabetic Foot Ulcer Treatment Market

29. Africa Diabetic Foot Ulcer Treatment Market

30. Diabetic Foot Ulcer Treatment Market Competitive Landscape And Company Profiles

31. Diabetic Foot Ulcer Treatment Market Other Major And Innovative Companies

32. Global Diabetic Foot Ulcer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetic Foot Ulcer Treatment Market

34. Recent Developments In The Diabetic Foot Ulcer Treatment Market

35. Diabetic Foot Ulcer Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기